1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Biogen Inc.
  6. Calendar
    BIIB   US09062X1037

BIOGEN INC.

(BIIB)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
199.65 USD   +3.40%
05/12Roche believes cancer drug setback not a fatal blow to growth prospects
RE
05/10Biogen Says Eisai Submits Biologics License Application for Lecanemab for Alzheimer's Disease to FDA
MT
05/09Eisai Completes Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab for Early Alzheimer's Disease Under the Accelerated Approval Pathway
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart BIOGEN INC.
Upcoming events on BIOGEN INC.
06/15/22 | 09:00am Annual General Meeting
07/26/22 Interim 2022 Earnings Release (Projected)
10/25/22 Q3 2022 Earnings Release (Projected)
02/02/23 FY 2022 Earnings Release (Projected)
04/25/23 Q1 2023 Earnings Release (Projected)
Past events on BIOGEN INC.
05/03/22 | 08:00am Q1 2022 Earnings Call
05/03/22 | 07:00am Q1 2022 Earnings Release
03/28/22 | 10:15am Stifel CNS Day
03/18/22 | 09:15am Alzheimer and Parkinson Diseases International Conference
03/18/22 | 09:00am Alzheimer and Parkinson Diseases International Conference
03/18/22 | 08:45am Alzheimer and Parkinson Diseases International Conference
03/18/22 | 04:40am Alzheimer and Parkinson Diseases International Conference
03/16/22 | 06:30am Alzheimer and Parkinson Diseases International Conference
03/15/22 | 02:00am Alzheimer and Parkinson Diseases International Conference
03/13/22 Muscular Dystrophy Association Clinical & Scientific Conference
Past dividends on BIOGEN INC.
02/02/17 0
Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
12 274
12 053
1,8%
13 453
13 320
1,0%
14 378
14 239
0,98%
13 445
13 368
0,57%
10 982
10 870
1,0%
 
9 834
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
6 647
7 276
-8,7%
7 038
7 440
-5,4%
8 070
8 396
-3,9%
7 504
7 558
-0,72%
4 144
4 352
-4,8%
 
3 577
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
6 380
6 313
1,1%
6 769
6 904
-2,0%
7 390
7 579
-2,5%
6 837
6 993
-2,2%
3 656
3 692
-0,97%
 
2 962
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
5 129
5 110
0,36%
5 900
6 056
-2,6%
7 126
6 968
2,3%
5 048
5 524
-8,6%
1 745
1 883
-7,3%
 
2 344
 
Net income
M $
Released
Forecast
Spread
2 539
3 846
-34%
4 431
4 730
-6,3%
5 889
5 757
2,3%
4 001
4 281
-6,5%
1 556
1 618
-3,8%
 
1 996
 
EPS
$
Released
Forecast
Spread
11,9
18,0
-34%
21,6
22,9
-5,7%
31,4
30,8
2,1%
24,8
26,6
-6,9%
10,4
10,8
-3,5%
 
14,1
 
Announcement Date01/25/201801/29/201901/30/202002/03/202102/03/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread
2 694
2 650
1,7%
2 775
2 612
6,2%
2 779
2 665
4,3%
2 734
2 621
4,3%
2 532
2 504
1,1%
 
2 486
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
1 185
1 179
0,52%
1 181
1 128
4,7%
1 018
1 045
-2,6%
781
944
-17%
844
904
-6,6%
 
843
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 038
1 006
3,2%
1 108
881
26%
885
782
13%
646
653
-1,1%
709
794
-11%
 
784
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
467
788
-41%
582
835
-30%
291
728
-60%
405
515
-21%
347
703
-51%
 
837
 
Net income
M $
Released
Forecast
Spread
410
615
-33%
449
579
-23%
329
507
-35%
368
417
-12%
304
550
-45%
 
734
 
EPS
$
Released
Forecast
Spread
2,69
4,15
-35%
2,99
4,25
-30%
2,22
3,52
-37%
2,50
2,88
-13%
2,06
3,74
-45%
 
5,54
 
Announcement Date04/22/202107/22/202110/20/202102/03/202205/03/2022-
Previous year Next Year
Upcoming sector events for BIOGEN INC.
More events
Past sector events for BIOGEN INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise